메뉴 건너뛰기




Volumn 42, Issue 10, 1998, Pages 2710-2717

Treatment of vancomycin-resistant Enterococcus faecium with RP 59500 (quinupristin-dalfopristin) administered by intermittent or continuous infusion, alone or in combination with doxycycline, in an in vitro pharmacodynamic infection model with simulated endocardial vegetations

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; DALFOPRISTIN; DALFOPRISTIN PLUS QUINUPRISTIN; DOXYCYCLINE; ERYTHROMYCIN; QUINUPRISTIN; RP 54496; UNCLASSIFIED DRUG; VANCOMYCIN;

EID: 0031658032     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.10.2710     Document Type: Article
Times cited : (44)

References (41)
  • 1
    • 0344313668 scopus 로고    scopus 로고
    • Pharmacodynamic analysis of quinupristin/dalfopristin (Q/D, Synercid) versus vancomycin-resistant Enterococcus faecium with differing MBCs using time-kill curve (KC) and postantibiotic effect (PAE) methods
    • abstr. E-136, American Society for Microbiology, Washington, D.C.
    • Aeschlimann, J. R., J. Rebuck, and M. J. Rybak. 1997. Pharmacodynamic analysis of quinupristin/dalfopristin (Q/D, Synercid) versus vancomycin-resistant Enterococcus faecium with differing MBCs using time-kill curve (KC) and postantibiotic effect (PAE) methods, abstr. E-136, p. 138. In Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
    • (1997) Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy , pp. 138
    • Aeschlimann, J.R.1    Rebuck, J.2    Rybak, M.J.3
  • 2
    • 0029134517 scopus 로고
    • Diversity among the gram-positive acetyltransferases inactivating streptogramin a and structurally related compounds and characterization of a new staphylococcal determinant, vatB
    • Allignet, J. and N. El Solh. 1995. Diversity among the gram-positive acetyltransferases inactivating streptogramin A and structurally related compounds and characterization of a new staphylococcal determinant, vatB. Antimicrob. Agents Chemother. 39:2027-2036.
    • (1995) Antimicrob. Agents Chemother. , vol.39 , pp. 2027-2036
    • Allignet, J.1    El Solh, N.2
  • 4
    • 0026663833 scopus 로고
    • Antimicrobial activity against Staphylococcus aureus of semisynthetic injectable streptogramins: RP 59500 and related compounds
    • Barriere, J. C., D. H. Bouanchaud, J. M. Paris, et al. 1992. Antimicrobial activity against Staphylococcus aureus of semisynthetic injectable streptogramins: RP 59500 and related compounds. J. Antimicrob. Chemother. 30(Suppl. A.):1-8.
    • (1992) J. Antimicrob. Chemother. , vol.30 , Issue.SUPPL. A , pp. 1-8
    • Barriere, J.C.1    Bouanchaud, D.H.2    Paris, J.M.3
  • 5
    • 0030978767 scopus 로고    scopus 로고
    • The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and humans
    • Bergeron, M., and G. Montay. 1997. The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and humans. J. Antimicrob. Chemother. 39(Suppl. A):129-138.
    • (1997) J. Antimicrob. Chemother. , vol.39 , Issue.SUPPL. A , pp. 129-138
    • Bergeron, M.1    Montay, G.2
  • 6
    • 0007261124 scopus 로고    scopus 로고
    • In vitro model for simultaneous simulation of the serum kinetics of two drugs with different half-lives
    • Blaser, J. In vitro model for simultaneous simulation of the serum kinetics of two drugs with different half-lives. J. Antimicrob. Chemother. 25:57-68
    • J. Antimicrob. Chemother. , vol.25 , pp. 57-68
    • Blaser, J.1
  • 7
    • 0030927287 scopus 로고    scopus 로고
    • Time-kill kinetics of quinupristin/dalfopristin on Staphylococcus aureus with and without a raised MBC evaluated by two methods
    • Boswell, F. J., J. Sunderland, J. M. Andrews, and R. Wise. 1997. Time-kill kinetics of quinupristin/dalfopristin on Staphylococcus aureus with and without a raised MBC evaluated by two methods. J. Antimicrob. Chemother. 39(Suppl. A):29-32.
    • (1997) J. Antimicrob. Chemother. , vol.39 , Issue.SUPPL. A , pp. 29-32
    • Boswell, F.J.1    Sunderland, J.2    Andrews, J.M.3    Wise, R.4
  • 8
    • 0026635188 scopus 로고
    • In vitro and in vivo synergic activity and fractional inhibitory concentration (FIC) of the components of a semisynthetic streptogramin, RP 59500
    • Bouanchaud, D. H. 1992. In vitro and in vivo synergic activity and fractional inhibitory concentration (FIC) of the components of a semisynthetic streptogramin, RP 59500. J. Antimicrob. Chemother. 30(Suppl. A):95-99.
    • (1992) J. Antimicrob. Chemother. , vol.30 , Issue.SUPPL. A , pp. 95-99
    • Bouanchaud, D.H.1
  • 9
    • 0031010340 scopus 로고    scopus 로고
    • In vitro and in vivo antibacterial activity of quinupristin/dalfopristin
    • Bouanchaud, D. H. 1997. In vitro and in vivo antibacterial activity of quinupristin/dalfopristin. J. Antimicrob. Chemother. 39(Suppl. A):15-21.
    • (1997) J. Antimicrob. Chemother. , vol.39 , Issue.SUPPL. A , pp. 15-21
    • Bouanchaud, D.H.1
  • 10
    • 0030833031 scopus 로고    scopus 로고
    • Influence of erythromycin resistance, inoculum growth phase, and incubation time on assessment of the bactericidal activity of RP 59500 (quinupristin-dalfopristin) against vancomycin-resistant Enterococcus faecium
    • Caron, F., H. S. Gold, C. B. Wennersten, M. G. Farris, R. C. Moellering, and G. M. Eliopoulos. 1997. Influence of erythromycin resistance, inoculum growth phase, and incubation time on assessment of the bactericidal activity of RP 59500 (quinupristin-dalfopristin) against vancomycin-resistant Enterococcus faecium. Antimicrob. Agents Chemother. 41:2749-2753.
    • (1997) Antimicrob. Agents Chemother. , vol.41 , pp. 2749-2753
    • Caron, F.1    Gold, H.S.2    Wennersten, C.B.3    Farris, M.G.4    Moellering, R.C.5    Eliopoulos, G.M.6
  • 12
    • 0027910517 scopus 로고
    • Nosocomial enterococci resistant to vancomycin - United States, 1989-1993
    • Centers for Disease Control and Prevention. 1993. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. Morbid. Mortal. Weekly Rep. 42:597-599.
    • (1993) Morbid. Mortal. Weekly Rep. , vol.42 , pp. 597-599
  • 13
    • 0028885871 scopus 로고
    • Quinupristin/dalfopristin (RP 59500): A new streptogramin antibiotic
    • Chant, C., and M. J. Rybak. 1995. Quinupristin/dalfopristin (RP 59500): a new streptogramin antibiotic. Ann. Pharmacother. 29:1022-1027.
    • (1995) Ann. Pharmacother. , vol.29 , pp. 1022-1027
    • Chant, C.1    Rybak, M.J.2
  • 14
    • 0031028394 scopus 로고    scopus 로고
    • Emergence of increased resistance to quinupristin/dalfopristin during therapy for Enterococcus faecium bacteremia
    • Chow, J. W., S. Donabedian, and M. J. Zervos. 1997. Emergence of increased resistance to quinupristin/dalfopristin during therapy for Enterococcus faecium bacteremia. Clin. Infect. Dis. 24:90-91.
    • (1997) Clin. Infect. Dis. , vol.24 , pp. 90-91
    • Chow, J.W.1    Donabedian, S.2    Zervos, M.J.3
  • 16
    • 0029072505 scopus 로고
    • Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500
    • Entenza, J. M., H. Drugeon, M. P. Glauser, and P. Moreillon. 1995. Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500. Antimicrob. Agents Chemother. 39:1419-1424.
    • (1995) Antimicrob. Agents Chemother. , vol.39 , pp. 1419-1424
    • Entenza, J.M.1    Drugeon, H.2    Glauser, M.P.3    Moreillon, P.4
  • 17
    • 0031000723 scopus 로고    scopus 로고
    • Influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics in Enterococcus faecium on activity of quinupristin-dalfopristin in vitro and in rabbits with experimental endocarditis
    • Fantin, B., R. LeClercq, L. Garry, and C. Carbon. 1997. Influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics in Enterococcus faecium on activity of quinupristin-dalfopristin in vitro and in rabbits with experimental endocarditis. Antimicrob. Agents Chemother. 41:931-935.
    • (1997) Antimicrob. Agents Chemother. , vol.41 , pp. 931-935
    • Fantin, B.1    LeClercq, R.2    Garry, L.3    Carbon, C.4
  • 18
    • 0028890892 scopus 로고
    • Critical influence of resistance to streptogramin B-type antibiotics on activity of RP 59500 (quinupristin/ dalfopristin) in experimental endocarditis due to Staphylococcus aureus
    • Fantin, B., R. Leclercq, Y. Merle, et al. 1995. Critical influence of resistance to streptogramin B-type antibiotics on activity of RP 59500 (quinupristin/ dalfopristin) in experimental endocarditis due to Staphylococcus aureus. Antimicrob. Agents Chemother. 39:400-405.
    • (1995) Antimicrob. Agents Chemother. , vol.39 , pp. 400-405
    • Fantin, B.1    Leclercq, R.2    Merle, Y.3
  • 19
    • 0028326207 scopus 로고
    • In vivo activities and penetration of the two components of the streptogramin RP 59500 in cardiac vegetations of experimental endocarditis
    • Fantin, B., R. Leclercq, M. Ottaviani, et al. 1994. In vivo activities and penetration of the two components of the streptogramin RP 59500 in cardiac vegetations of experimental endocarditis. Antimicrob. Agents Chemother. 38:432-437.
    • (1994) Antimicrob. Agents Chemother. , vol.38 , pp. 432-437
    • Fantin, B.1    Leclercq, R.2    Ottaviani, M.3
  • 20
    • 0029246680 scopus 로고
    • Recommendations for preventing the spread of vancomycin resistance
    • Hospital Infection Control Practices Advisory Committee. 1995. Recommendations for preventing the spread of vancomycin resistance. Infect. Control Hosp. Epidemiol. 16:105-113.
    • (1995) Infect. Control Hosp. Epidemiol. , vol.16 , pp. 105-113
  • 21
    • 0344307469 scopus 로고    scopus 로고
    • Streptogramin combination (quinupristin/daltopristin) activity and spectrum from a 1997 study in over 200 medical centers: Analysis for regional variations, co-resistances, and validity of proposed susceptibility breakpoints
    • abstr. E-134, American Society for Microbiology, Washington, D.C.
    • Jones R. N., C. H. Ballow, D. Biedenbach, J. J. Schentag, and the SMART Study Group. 1997. Streptogramin combination (quinupristin/daltopristin) activity and spectrum from a 1997 study in over 200 medical centers: analysis for regional variations, co-resistances, and validity of proposed susceptibility breakpoints, abstr. E-134, p. 137. In Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
    • (1997) Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy , pp. 137
    • Jones, R.N.1    Ballow, C.H.2    Biedenbach, D.3    Schentag, J.J.4
  • 22
    • 0029017737 scopus 로고
    • Pharmacodynamics of RP 59500 alone and in combination with vancomycin against Staphylococcus aureus in an in vitro infected fibrin clot model
    • Kang, S. L. and M. J. Rybak. 1995. Pharmacodynamics of RP 59500 alone and in combination with vancomycin against Staphylococcus aureus in an in vitro infected fibrin clot model. Antimicrob. Agents Chemother. 39:1505-1511.
    • (1995) Antimicrob. Agents Chemother. , vol.39 , pp. 1505-1511
    • Kang, S.L.1    Rybak, M.J.2
  • 23
    • 0029920413 scopus 로고    scopus 로고
    • Emerging problems with enterococcal infections
    • LeClercq, R., and P. Courvalin. 1996. Emerging problems with enterococcal infections. Curr. Opin. Infect. Dis. 9:115-119.
    • (1996) Curr. Opin. Infect. Dis. , vol.9 , pp. 115-119
    • LeClercq, R.1    Courvalin, P.2
  • 24
    • 0023808730 scopus 로고
    • Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium
    • Leclerq, R. E. Deroit, J. Duval, and P. Courvalin. 1988. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med. 319:157-161.
    • (1988) N. Engl. J. Med. , vol.319 , pp. 157-161
    • Leclerq, R.1    Deroit, E.2    Duval, J.3    Courvalin, P.4
  • 25
    • 0026684265 scopus 로고
    • Activity of RP 59500, a new patenteral semisynthetic streptogramin against staphylococci with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibiotics
    • Leclercq, R., L. Nantas, C. J. Soussy, and J. Duval. 1992. Activity of RP 59500, a new patenteral semisynthetic streptogramin against staphylococci with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibiotics. J. Antimicrob. Chemother. 30(Suppl. A):67-76.
    • (1992) J. Antimicrob. Chemother. , vol.30 , Issue.SUPPL. A , pp. 67-76
    • Leclercq, R.1    Nantas, L.2    Soussy, C.J.3    Duval, J.4
  • 26
    • 0015461536 scopus 로고
    • Doxycycline blood levels in normal subjects after intravenous and oral administration
    • Liebowitz, B., J. L. Hakes, M. M. Cahn, et al. 1972. Doxycycline blood levels in normal subjects after intravenous and oral administration. Curr. Ther. Res. Clin. Exp. 14:820-831.
    • (1972) Curr. Ther. Res. Clin. Exp. , vol.14 , pp. 820-831
    • Liebowitz, B.1    Hakes, J.L.2    Cahn, M.M.3
  • 27
    • 0028124419 scopus 로고
    • Bactericidal activities of teicoplanin, vancomycin, and gentamicin alone and in combination against Staphylococcus aureuis in an in vitro pharmacodynamic model of endocarditis
    • McGrath, B. J., S. L. Kang, G. W. Kaatz, and M. J. Rybak. 1994. Bactericidal activities of teicoplanin, vancomycin, and gentamicin alone and in combination against Staphylococcus aureuis in an in vitro pharmacodynamic model of endocarditis. Antimicrob. Agents Chemother. 38:2034-2040.
    • (1994) Antimicrob. Agents Chemother. , vol.38 , pp. 2034-2040
    • McGrath, B.J.1    Kang, S.L.2    Kaatz, G.W.3    Rybak, M.J.4
  • 28
    • 0026755890 scopus 로고
    • Enterococcal endocarditis
    • Megran, D. W. 1992. Enterococcal endocarditis. Clin. Infect. Dis. 15:63-71.
    • (1992) Clin. Infect. Dis. , vol.15 , pp. 63-71
    • Megran, D.W.1
  • 29
    • 0345608138 scopus 로고
    • Selection of Enterococcus faecium strains with stable and unstable resistance to RP 59500 using stepwise exposure in vitro
    • abstr. E-120, American Society for Microbiology, Washington, D.C.
    • Millichap, J., T. Ristow, U. Bodner, et al. 1995. Selection of Enterococcus faecium strains with stable and unstable resistance to RP 59500 using stepwise exposure in vitro, abstr. E-120, p. 106. In Abstracts ot the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
    • (1995) Abstracts Ot the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy , pp. 106
    • Millichap, J.1    Ristow, T.2    Bodner, U.3
  • 30
    • 0030152388 scopus 로고    scopus 로고
    • Selection of Enterococcus faecium strains with stable and unstable resistance to the streptogramin RP 59500 using stepwise in vitro exposure
    • Millichap, J., T. A. Ristow, G. A. Noskin, and L. R. Peterson. 1996. Selection of Enterococcus faecium strains with stable and unstable resistance to the streptogramin RP 59500 using stepwise in vitro exposure. Diagn. Microbiol. Infect. Dis. 25:15-20.
    • (1996) Diagn. Microbiol. Infect. Dis. , vol.25 , pp. 15-20
    • Millichap, J.1    Ristow, T.A.2    Noskin, G.A.3    Peterson, L.R.4
  • 32
    • 0345176043 scopus 로고    scopus 로고
    • Low rates of emerging resistance and superinfection in Synercid (quinupristin/ dalfopristin Q/D) treated patients during worldwide clinical program
    • abstr. E-136B, American Society for Microbiology, Washington, D.C.
    • Nadler, H., M. Dowzicky, G. Talbot, F. Bompart, and F. Grote. 1997. Low rates of emerging resistance and superinfection in Synercid (quinupristin/ dalfopristin Q/D) treated patients during worldwide clinical program, abstr. E-136B, p. 5. In Program and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
    • (1997) Program and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy , pp. 5
    • Nadler, H.1    Dowzicky, M.2    Talbot, G.3    Bompart, F.4    Grote, F.5
  • 34
    • 0028352613 scopus 로고
    • Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureus
    • Nicolau, D. P., C. D. Freeman, C. H. Nightingale, C. J. Coe, and R. Quintilliani. 1994. Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 38:1515.
    • (1994) Antimicrob. Agents Chemother. , vol.38 , pp. 1515
    • Nicolau, D.P.1    Freeman, C.D.2    Nightingale, C.H.3    Coe, C.J.4    Quintilliani, R.5
  • 36
    • 0345176041 scopus 로고    scopus 로고
    • Acquired resistance to quinupristin/dalfopristin (Synercid®) during successful antimicrobial therapy ot vancomycin-resistant enterococcus (VRE)
    • abstr. A-109, American Society for Microbiology,. Washington,. D.C.
    • Piper, J., L. Steele-Moore, and D. Berg. 1996. Acquired resistance to quinupristin/dalfopristin (Synercid®) during successful antimicrobial therapy ot vancomycin-resistant enterococcus (VRE), abstr. A-109, p. 152. In Abstracts of the 96th General Meeting of the American Society for Microbiology. American Society for Microbiology,. Washington,. D.C.
    • (1996) Abstracts of the 96th General Meeting of the American Society for Microbiology , pp. 152
    • Piper, J.1    Steele-Moore, L.2    Berg, D.3
  • 37
    • 0343436905 scopus 로고    scopus 로고
    • High level cross-resistance to macrolides and lincomycin in streptococci and enterococci: Constitutive or inducible expression of ribosomal methylase?
    • abstr. C-81, American Society for Microbiology, Washington, D.C.
    • Rosato, A., H. Vicarini, and R. Leclereq. 1996. High level cross-resistance to macrolides and lincomycin in streptococci and enterococci: constitutive or inducible expression of ribosomal methylase?, abstr. C-81, p. 49. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
    • (1996) Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy , pp. 49
    • Rosato, A.1    Vicarini, H.2    Leclereq, R.3
  • 38
    • 0343059368 scopus 로고
    • Analysis of genome organizations and rearrangements by pulsed field gradient gel electrophoresis
    • J. K. Setlow and A. Hollaender (ed.), Plenum Press, New York, N.Y.
    • Smith, C. L., P. E. Warburton, A. Gaal, and C. R. Cantor. 1986. Analysis of genome organizations and rearrangements by pulsed field gradient gel electrophoresis, p. 45-70. In J. K. Setlow and A. Hollaender (ed.), Genetic engineering, principles and methods. Plenum Press, New York, N.Y.
    • (1986) Genetic Engineering, Principles and Methods , pp. 45-70
    • Smith, C.L.1    Warburton, P.E.2    Gaal, A.3    Cantor, C.R.4
  • 40
    • 0023837814 scopus 로고
    • Vancomycin-resistant enterococci
    • Uttley, A. H. C., C. H. Collins, J. Naidoo, et al. 1988. Vancomycin-resistant enterococci. Lancet i:57-58.
    • (1988) Lancet , vol.1 , pp. 57-58
    • Uttley, A.H.C.1    Collins, C.H.2    Naidoo, J.3
  • 41
    • 0030957155 scopus 로고    scopus 로고
    • Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus spp.
    • Williams, J. D., J. P. Maskell, A. C. Whiley, and A. M. Sefton. 1997. Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus spp. J. Antimicrob. Chemother. 39(Suppl. A):41-46.
    • (1997) J. Antimicrob. Chemother. , vol.39 , Issue.SUPPL. A , pp. 41-46
    • Williams, J.D.1    Maskell, J.P.2    Whiley, A.C.3    Sefton, A.M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.